Cuervas-Mons V - Search Results

1

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrión VS, Barrios C, Moreno E, Noriega AR, Paya CV. Lumbreras C, et al. J Infect Dis. 1996 Sep;174(3):583-8. doi: 10.1093/infdis/174.3.583. J Infect Dis. 1996. PMID: 8769617 Clinical Trial.

2

Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas.

De la Revilla NJ, Moreno JM, Rubio E, de Herreros TA, Navarrete E, Lopez MJ, Turrion VS, Jimenez M, Lucena M, Cuervas-Mons V. De la Revilla NJ, et al. Transplant Proc. 2003 Aug;35(5):1830-1. doi: 10.1016/s0041-1345(03)00583-9. Transplant Proc. 2003. PMID: 12962812

3

De novo malignancies and liver transplantation.

Rubio E, Moreno JM, Turrión VS, Jimenez M, Lucena JL, Cuervas-Mons V. Rubio E, et al. Transplant Proc. 2003 Aug;35(5):1896-7. doi: 10.1016/s0041-1345(03)00645-6. Transplant Proc. 2003. PMID: 12962838

4

Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality.

Moreno JM, Cuervas-Mons V, Rubio E, Pons F, Herreros de T A, Turrión VS, Millán I. Moreno JM, et al. Transplant Proc. 2003 Aug;35(5):1907-8. doi: 10.1016/s0041-1345(03)00642-0. Transplant Proc. 2003. PMID: 12962843

5

Renal failure after liver transplantation: analysis of risk factors in 139 liver transplant recipients.

Nuño J, Cuervas-Mons V, Vicente E, Turrión V, Pereira F, Mora NP, Barrios C, Millán I, Ardaiz J. Nuño J, et al. Transplant Proc. 1995 Aug;27(4):2319-20. Transplant Proc. 1995. PMID: 7652826 No abstract available.

6

Metabolic effects of liver replacement in homozygous familial hypercholesterolemia.

Cienfuegos JA, Pardo F, Turrión VS, Ardaiz J, Mora NP, Escartín P, Garrido A, Barrios C, Cuervas-Mons V. Cienfuegos JA, et al. Transplant Proc. 1987 Oct;19(5):3815-7. Transplant Proc. 1987. PMID: 3313932 No abstract available.

7

Cardiovascular morbidity and obesity in adult liver transplant recipients.

Mazuelos F, Abril J, Zaragoza C, Rubio E, Moreno JM, Turrión VS, Cuervas-Mons V. Mazuelos F, et al. Transplant Proc. 2003 Aug;35(5):1909-10. doi: 10.1016/s0041-1345(03)00640-7. Transplant Proc. 2003. PMID: 12962844

8

Is the use of University of Wisconsin solution with prolonged ischemia time an option in clinical liver transplantation?

Nuño J, Cuervas-Mons V, Vicente E, Turrión V, Pereira F, Mora NP, Barrios C, Millán I, Ardaiz J. Nuño J, et al. Transplant Proc. 1995 Aug;27(4):2288-9. Transplant Proc. 1995. PMID: 7652809 No abstract available.

9

Renin-angiotensin-aldosterone system and arterial hypertension following orthotopic liver transplantation.

Leal JC, Marín MC, Barrios C, Garrido A, Albillos A, Ortiz Berrocal J, Cuervas-Mons V. Leal JC, et al. Transplant Proc. 1993 Apr;25(2):1768. Transplant Proc. 1993. PMID: 8470158 No abstract available.

10

Influence of infection by Aspergillus in arterial complications after liver transplantation: evolution and results in 670 transplants.

Rubio E, Jimenez M, Alvira LG, Lucena JL, Arrieta FM, Chaparro MD, Cuervas-Mons V, Turrión VS. Rubio E, et al. Transplant Proc. 2011 Apr;43(3):751-2. doi: 10.1016/j.transproceed.2011.03.005. Transplant Proc. 2011. PMID: 21486591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters